Dr. Gerson Suarez Cedeno, MD

Dr. Suarez Cedeno practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Suarez Cedeno's NPI, 1376951442, was assigned on August 1, 2014. Dr. Suarez Cedeno holds New Mexico license MD2020-0016.

Dr. Suarez Cedeno's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Suarez Cedeno's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Suarez Cedeno to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suarez Cedeno practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Suarez Cedeno's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Suarez Cedeno is licensed in New Mexico.

CMS data shows 513 Medicare services from Dr. Suarez Cedeno across 6 procedure codes in 2024, for 198 Medicare patients. Medicare paid $40,597 for them. Every service was in an office.

CMS counts 198 Medicare patients who saw Dr. Suarez Cedeno in 2024. The largest group is 65 to 74, with 96 patients. 64% of them have high cholesterol, and 63% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Suarez Cedeno's median patient age at 73, with 47% women.

In 2024, Dr. Suarez Cedeno wrote 873 Medicare Part D claims for 205 patients. 93% of them were for generic drugs. CMS names the drug for 774 of them, across 14 drugs with 11 or more claims each, at $170,977 in total drug cost. In 2023, CMS named 749 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Suarez Cedeno for performance year 2024, reported as part of a group. Dr. Suarez Cedeno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Suarez Cedeno as offering telehealth.

CMS Open Payments shows 17 general payments to Dr. Suarez Cedeno from 4 drug and device companies from 2018 to 2023. Grants make up the largest share, 97% of the total. Medtronic USA, Inc. paid the most, $45,149.